The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Hyrnuo (sevabertinib) for adults with locally ...

The FDA has withdrawn its accelerated approval of Krazati (adagrasib) combined with Erbitux (cetuximab) for adults with KRAS G12C-mutated colorectal cancer that is locally advanced or has spread to ...

Upcoming changes to how Medicare handles ostomy supplies could affect cancer survivors who rely on specific products after treatment, according to Dr. Diego Schaps.

For patients receiving chemotherapy for aggressive lymphoma, we may see lower blood counts, which can increase the risk of infection. Some patients may need blood or platelet transfusions. Hair loss ...

Dr. Diego Schaps discussed how upcoming Medicare competitive bidding changes could affect access to ostomy supplies and why having the right pouching system matters for patients.

Alcohol-attributable cancer deaths more than doubled from 1990 to 2023, and the national age-standardized mortality rate rose ...

Arlo-cel uses autologous T-cell collection, ex vivo CAR engineering, lymphodepletion, and single infusion, necessitating infrastructure for manufacturing logistics and post-infusion monitoring. Safety ...

Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb on "Investigating Myeloma," a disease awareness ...

Therapy planning shifted from intended autologous transplant to CAR-T; detailed counseling helped align expectations and ...

Cancer survivor Brynn Forlizzi and caregiver Teddy Aaron created SootheNote, an app designed to help cancer patients and ...

Please check back later for more content.

Gonadotoxic therapy can abruptly threaten fertility in AYA breast cancer, making preservation counseling time-sensitive and ...